Sean Z. Zhao, MD, PhD

home / authors / sean-z-zhao-md-phd

Articles

October 1st 2002

Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Sean Z. Zhao, MD, PhD Thomas A. Burke, PharmD, MPH Andrew Whelton, MD, PhD Heather von Allmen Scott C. Henderson, MS

October 1st 2002

Blood Pressure Destabilization and Related Healthcare Utilization Among Hypertensive Patients Using Nonspecific NSAIDs and COX-2-Specific Inhibitors

Sean Z. Zhao, MD, PhD Thomas A. Burke, PharmD, MPH Andrew Whelton, MD, PhD Heather von Allmen Scott C. Henderson, MS

October 1st 2002

Cost of Heart Failure Among Hypertensive Users of Nonspecific NSAIDs and COX-2-Specific Inhibitors

Sean Z. Zhao, MD, PhD Thomas A. Burke, PharmD, MPH Andrew Whelton, MD, PhD Heather von Allmen Scott C. Henderson, MS

October 1st 1999

Healthcare Utilization Associated with Dyspepsia in Patients with Arthritis

Sean Z. Zhao, MD, PhD Lester M. Arguelles, MS Seema D. Dedhiya, MS David G. Morgan, MD

May 1st 1999

The Cost of Inpatient Endometriosis Treatment: An Analysis Based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample

Sean Z. Zhao, MD, PhD Josephine M. Wong, PharmD Mary Beth Davis, MBA Gail E. Gersh, PhD Kenneth E. Johnson, PharmD

August 1st 1998

The Cost of Inpatient Endometriosis Treatment: An Analysis Based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample

Sean Z. Zhao, MD, PhD Josephine M. Wong, PharmD Mary Beth Davis Gail E. Gersh, PhD Kenneth E. Johnson, PharmD

March 1st 1998

Prevalence and Cost of Hospitalization for Gastrointestinal Complications Related to Peptic Ulcers with Bleeding or Perforation: Comparison of Two National Databases

Sheldon X. Kong, PhD Hind T. Hatoum, PhD Sean Z. Zhao, MD, PhD Naurang M. Argrawal, MD Steve G. Geis, MD, PhD

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Insights from the TROPION-Lung05 Trial at ASCO 2024

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School

Published: July 24th 2024 | Updated: July 27th 2024

Examining Trends, Future Directions in AI and Health Care

Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Alfred L. Garfall, MD, an expert on multiple myeloma

Published: July 24th 2024 | Updated: July 27th 2024

Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions